Buy HIMS near 25.88 target 32.47 stop loss @ 25.81 Details The technical summary data tells us to buy HIMS near 25.88 with an ...

It’s been nearly five years since the coronavirus broke out in the U.S., but digital health companies are still reeling.

The Short discusses a 15% drop in Hims & Hers stock following an FDA announcement ending the shortage of Eli Lilly's weight ...

Tirzepatide, the active ingredient in both Mounjaro for type 2 diabetes and Zepbound for weight loss, was in short supply for ...

Disappointing trial results for Novo Nordisk A/S’s experimental obesity shot capped a volatile year for investors in drug ...

Hims recaps the year's most surprising health findings, from the growing number of adults who consider monogamy optional to ...

Craig Hettenbach, an analyst from Morgan Stanley, maintained the Buy rating on Hims & Hers Health (HIMS – Research Report). The associated ...

Oza’s new Miami Beach home was built in 1936 and sculpted by architect Lawrence Murray Dixon, who owned it as a personal ...

Hims & Hers is transforming telehealth with personalized medications, rapid subscription growth, and strong financials, ...

Specialty pharmacies and online companies that have been selling off-brand copies of two blockbuster drugs for obesity and ...

One reason why the Hims & Hers stock price surged has been its entry into the weight loss industry, where it offers quality ...

Since pharmaceutical giant Eli Lilly (NYSE: LLY) reported earnings for the third quarter on Oct. 30, shares have been ...